RNS Number : 5415U
Legal & General UCITS ETF PLC
29 July 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
29/07/2020 |
IE00BFXR5Q31 |
11767267 |
USD |
144725602.06 |
12.299 |
| L&G UK Equity UCITS ETF |
29/07/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
10885148.61 |
9.071 |
| L&G Global Equity UCITS ETF |
29/07/2020 |
IE00BFXR5S54 |
2900000 |
USD |
34310127.85 |
11.831 |
| L&G Japan Equity UCITS ETF |
29/07/2020 |
IE00BFXR5T61 |
11185000 |
USD |
119099643.85 |
10.648 |
| L&G Europe ex UK Equity UCITS ETF |
29/07/2020 |
IE00BFXR5V83 |
9360988 |
EUR |
102553531.52 |
10.955 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
29/07/2020 |
IE00BFXR5W90 |
4981427 |
USD |
53093494.11 |
10.658 |
| L&G Clean Water UCITS ETF |
29/07/2020 |
IE00BK5BC891 |
1500000 |
USD |
16600806.54 |
11.067 |
| L&G Artificial Intelligence UCITS ETF |
29/07/2020 |
IE00BK5BCD43 |
7946000 |
USD |
108545754.39 |
13.660 |
| L&G Healthcare Innovation UCITS ETF |
29/07/2020 |
IE00BK5BC677 |
3000000 |
USD |
41216224.79 |
13.739 |
| L&G Pharma Breakthrough UCITS ETF |
29/07/2020 |
IE00BF0H7608 |
2150000 |
USD |
25905709.64 |
12.049 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
29/07/2020 |
IE00BKLTRN76 |
9200000 |
EUR |
95196813.17 |
10.347 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
29/07/2020 |
IE00BKLWY790 |
57800000 |
USD |
640420113.06 |
11.080 |
| L&G Battery Value-Chain UCITS ETF |
29/07/2020 |
IE00BF0M2Z96 |
13200000 |
USD |
135954348.98 |
10.300 |
| L&G Ecommerce Logistics UCITS ETF |
29/07/2020 |
IE00BF0M6N54 |
9600000 |
USD |
109256882.44 |
11.381 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
29/07/2020 |
IE00BMW3QX54 |
46830616 |
USD |
860350310.61 |
18.372 |
| L&G Cyber Security UCITS ETF |
29/07/2020 |
IE00BYPLS672 |
82611776 |
USD |
1669096482.03 |
20.204 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVKZGZNZLKGGZZ
